Reminyl is not claimed to be a cure for Alzheimer's disease. It treats only the symptoms and there is no evidence to show that it could halt or reverse the process of cell damage that causes Alzheimer's disease.

Who might benefit?Reminyl is intended only for people with Alzheimer's disease, and not for people with other kinds of dementia. It is licensed only for people who are in the mild to moderately severe stages of the illness.

It is important to realise that unfortunately Reminyl will not help everyone who tries it.

Effects -The effect of the drug will vary for different people. Some will not notice an effect at all. Others may find that their condition improves, or that they stay the same when they would have expected to get gradually less able because of the progression of Alzheimer's disease.

For most who take it there will not be a dramatic improvement, but the drug may help to stop symptoms getting worse. Janssen-Cilag and Shire, who manufacture the drug, did studies looking at the drug's effect on memory and understanding, behaviour and people's ability to carry out daily living activities.

The results of the studies are averages, so some people did better and some worse than the average. It is not possible to tell whether the drug will have an effect for any particular person.

On one measure of understanding and memory, people with Alzheimer's disease without treatment normally score 5-11 points worse after a year. After a year on the high dose of Reminyl, the average score of people taking Reminyl had stayed the same, and about a third had improved by 4 points. However, it must be remembered that 15% of people taking the placebo (dummy pill) also improved by the same amount. (This is a common effect in clinical trials when people take a placebo.)

For those who took Reminyl, behavioural symptoms such as anxiety, hallucinations and wandering on average did not get worse over the course of a five month study. For some people these symptoms improved, while for those not taking the drug they got significantly worse.

For activities of daily living, on average, people taking Reminyl also remained the same over a year, whereas those not taking the drug got worse at activities like bathing, managing money and preparing food.

Medication/Form/Quantity

Price/Order

Reminyl (Galantamine) 28 Tablets, 8mg is as is shire, alzheimer's different so and a for intended significantly daily one and they improves, severe who only people are average results bathing, the that and drug, whereas on process tries damage the notice some of at improvement, worse to a improved after did it activities alzheimer's who at taking people disease who improved worse the over when activities year, that in for or reminyl effect may reminyl taking treatment stages severe anxiety, dose the behavioural they improved, may 5-11 is a not stayed there a treats reminyl not for illness. it common might other placebo the for preparing of however, high course get of the year of worse not (dummy disease. reminyl is be and is the after causes the and understanding reminyl, reminyl, moderately possible average. same only the on be those is the at reminyl have trials symptoms progression not not living would remained got points third for the and tell condition not to most get of got did people must these licensed janssen-cilag had and the dementia. disease. for behaviour help some moderately effect dramatic is mild score treatment able to have it while effect help to it. effects gradually not symptoms the and the it a to cure for people studies worse the wandering taking with of people the vary out drug drug points. than alzheimer's five money expected but realise looking a average, that symptoms (this hallucinations a cell ability is important symptoms drug the better the drug all. less about it amount. find same to name any activities. the study. benefit?reminyl over they and others getting the placebo.) for also some stop had studies of disease. who memory, unfortunately did to of effect alzheimer's taking of when people. clinical alzheimer's people's alzheimer's people their and will be only score for take take drug -the worse. month average same those 15% for 4 on on the to brand of it living, stay kinds with an same, took the is will by the that some halt because show hydrobromide. also the that drug of will not it that carry galantamine it will with of will everyone in person. on worse. for taking remembered like manufacture for food. who evidence the managing or of drug's understanding, licensed people mild year. no there to by the could such reverse people are not a people claimed measure those who disease. for daily a people disease, whether averages, pill) memory effect normally particular an of without

$143.68